[Bora] Subsidiary Bora Global Ltd. Announces Fund Lending to Bora Pharmaceuticals USA Inc. under Public Company Fund Lending and Guarantee Regulations

1. Date of Event: 115/06/18

2. Recipient of Fund Lending: (1) Company Name: Bora Pharmaceuticals USA Inc. (2) Relationship with Lending Entity: Direct 100% subsidiary of the company (funds lent by subsidiary Bora Global Ltd.) (3) Lending Limit (in NT$ thousands): 3,897,602 (4) Previous Outstanding Balance (in NT$ thousands): 0 (5) Amount of New Lending (in NT$ thousands): 2,573,770 (6) Whether the Board authorized the Chairman to conduct multiple or revolving loans to the same recipient: No (7) Outstanding Lending Balance as of Event Date (in NT$ thousands): 2,573,770 (8) Reason for New Lending: To supplement working capital required for the acquisition of CDMO operating assets in Maryland

3. Collateral Provided by Borrower: (1) Description: None (2) Value (in NT$ thousands): 0

4. Latest Financial Statement of Borrower: (1) Capital (in NT$ thousands): 15,790 (2) Accumulated Profits/Losses (in NT$ thousands): 1,249,606

5. Interest Calculation Method: Annual interest rate of 5.2%

6. Repayment Terms: (1) Conditions: Full repayment of principal and interest at maturity (2) Date: Within one year from the date of borrowing

7. Total Outstanding Lending Balance as of Event Date (in NT$ thousands): 2,573,770

8. Ratio of Outstanding Lending Balance to Net Equity of the Public Company (based on latest financials): 17.67%

9. Source of Lending Funds: The subsidiary itself

10. Other Disclosures: None